Trade

with

Fresenius Medical Care AG & Co. KGaA
(NYSE: FMS)
AdChoices
34.29
-0.20
-0.58%
After Hours :
34.30
+0.01
+0.03%

Open

34.50

Previous Close

34.49

Volume (Avg)

99.06k (105.12k)

Day's Range

34.29-34.57

52Wk Range

31.28-37.01

Market Cap.

20.85B

Dividend Rate (Yield )

0.37 (1.07%)

Beta

0.55

Shares Outstanding

604.61M

P/E Ratio (EPS)

19.49 (1.77)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Care
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 14.61B

    • Net Income

    • 1.11B

    • Market Cap.

    • 20.85B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 7.11

    • PEG (Price/Earnings Growth) Ratio

    • 1.01

    • Beta

    • 0.55

    • Forward P/E

    • 9.68

    • Price/Sales

    • 1.38

    • Price/Book Value

    • 2.22

    • Price/Cash flow

    • 11.78

      • EBITDA

      • 2.94B

      • Return on Capital %

      • 4.57

      • Return on Equity %

      • 11.64

      • Return on Assets %

      • 4.57

      • Book Value/Share

      • 15.52

      • Shares Outstanding

      • 604.61M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.37 (5/13/2014)

      • Dividend Declaration Date

      • 5/6/2014

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 63.31

        • Credit Rating

        • BB+

        • Analysts

        • 5

        • EPS Estimate

        • 3.83

        • Cashflow Estimate

        • 6.28

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 6.20

          • 10.91

          • Net Income

            YTD/YTD (last year)

          • -6.50

          • 13.51

          • Net Income

            Q/Q (last year)

          • -11.00

          • 9.25

          • Sales (Revenue)

            5-Year Annual Average

          • 6.60

          • 22.28

          • Net Income

            5-Year Annual Average

          • 6.30

          • 7.43

          • Dividends

            5-Year Annual Average

          • -3.16

          • 7.69

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 31.91

            • 20.03

            • Pre-Tax Margin

            • 12.21

            • 6.27

            • Net Profit Margin

            • 7.11

            • 3.77

            • Average Gross Margin

              5-Year Annual Average

            • 33.90

            • 20.79

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 13.40

            • 6.01

            • Average Net Profit Margin

              5-Year Annual Average

            • 8.10

            • 210.16B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.90

              • 0.69

              • Current Ratio

              • 1.85

              • 1.48

              • Quick Ratio

              • 1.09

              • 0.75

              • Interest Coverage

              • 5.09

              • 11.79

              • Leverage Ratio

              • 2.57

              • 2.42

              • Book Value/Share

              • 15.52

              • 17.00

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 19.49

                • 24.39

                • P/E Ratio 5-Year High

                • 22.63

                • 103.00

                • P/E Ratio 5-Year Low

                • 13.33

                • 15.89

                • Price/Sales Ratio

                • 1.38

                • 0.85

                • Price/Book Value

                • 2.22

                • 3.30

                • Price/Cash Flow Ratio

                • 11.78

                • 11.33

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 11.64

                    (13.60)

                  • 12.59

                    (10.63)

                  • Return on Assets %

                    (5-Year Average)

                  • 4.57

                    (5.60)

                  • 6.43

                    (5.79)

                  • Return on Capital %

                    (5-Year Average)

                  • 7.63

                    (9.20)

                  • 8.91

                    (7.75)

                  • Income/Employee

                  • 10.94k

                  • 8.31k

                  • Inventory Turnover

                  • 8.71

                  • 9.85

                  • Asset Turnover

                  • 0.64

                  • 1.70

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  2.26B
                  Operating Margin
                  15.44
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  11.78
                  Ownership

                  Institutional Ownership

                  2.28%

                  Top 10 Institutions

                  1.52%

                  Mutual Fund Ownership

                  0.21%

                  Float

                  -

                  5% / Insider Ownership

                  -

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • PowerShares Intl Div Achiev™ Port

                  •  

                    325,737

                  • 0.00

                  • 0.05

                  • Delaware Healthcare Fund

                  •  

                    200,000

                  • 0.00

                  • 0.03

                  • Manning & Napier International Series

                  •  

                    200,000

                  • 0.00

                  • 0.03

                  • Robeco Boston Partners Long/Short Equity

                  •  

                    196,496

                  • 0.00

                  • 0.03

                  • DFA International Core Equity Portfolio

                  •  

                    53,000

                  • 0.00

                  • 0.01

                  • Timothy Plan International Fund

                  •  

                    44,000

                  • 22.22

                  • 0.01

                  • Comerica Foreign Equity CIT - Inst Class

                  •  

                    22,537

                  • 13.25

                  • 0.00

                  • Manning & Napier Maximum Term

                  •  

                    18,760

                  • 39.69

                  • 0.00

                  • Praxis International Index Fund

                  •  

                    17,810

                  • 0.00

                  • 0.00

                  • Manning & Napier Extended Term

                  •  

                    16,510

                  • 0.00

                  • 0.00

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Thornburg Investment Management, Inc.

                  •  

                    2,966,895

                  • -7.62%

                  • 0.49

                  • Harding Loevner L.P.

                  •  

                    2,061,150

                  • -21.35%

                  • 0.34

                  • Northern Trust Investments, N.A.

                  •  

                    832,888

                  • +4.37%

                  • 0.14

                  • Marathon Asset Management LLP

                  •  

                    826,661

                  • -7.66%

                  • 0.14

                  • Goldman Sachs Asset Management, L.P.

                  •  

                    703,432

                  • -18.88%

                  • 0.12

                  • Managed Account Advisors LLC

                  •  

                    422,946

                  • -13.16%

                  • 0.07

                  • Jarislowsky Fraser Ltd

                  •  

                    406,105

                  • +2.08%

                  • 0.07

                  • Invesco PowerShares Capital Mgmt LLC

                  •  

                    331,653

                  • +39.01%

                  • 0.05

                  • Royal Bank Of Canada

                  •  

                    301,672

                  • +15.93%

                  • 0.05

                  • Manning & Napier Advisors, LLC

                  •  

                    279,080

                  • +1.95%

                  • 0.05

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Care

                  Type

                  Classic Growth

                  Style

                  Large Growth

                  Fresenius Medical Care AG & Co. KGaA was incorporated on August 5, 1996. It is a kidney dialysis company, operating in both the field of dialysis products and the field of dialysis services. The Company’s dialysis business is vertica...morelly integrated, providing dialysis treatment at its own dialysis clinics and supplying these clinics with a range of products. In addition, to providing dialysis treatments, includes pharmacy services and vascular access surgery services. It sells dialysis products to other dialysis service providers. It also develops and manufactures equipment, systems and disposable products, which it sells to customers in over 120 countries. It offers life-maintaining and life-saving dialysis services and products in a market which is characterized by a favorable demographic developme...morent. It provides expanded and enhanced patient services, including renal pharmaceutical products and laboratory services, to both its own clinics and those of third parties. The Company’s clinics also provide services for home dialysis patients, the majority of whom receive peritoneal dialysis treatment. It also provides dialysis services under contract to hospitals in the U.S. on an ‘as needed’ basis for hospitalized ESRD patients and for patients suffering from acute kidney failure. The Company provides laboratory testing and marketing services in the U.S. through Spectra Laboratories (Spectra). Spectra provides blood, urine and other bodily fluid testing services to determine the appropriate individual dialysis therapy for a patient and to assist physicians in determining whether a dialysis patient’s therapy regimen, diet and medicines remain optimal. The Company’s main trademarks are the name ‘Fresenius’ and the ‘F’ logo’. The Company’s competitors in the sale of hemodialysis and peritoneal dialysis products include, Baxter International Inc., Asahi Kasei Kuraray Medical Co. Ltd., Bellco S.r.l., B. Braun Melsungen AG, Nipro Corporation Ltd., Nikkiso Co., Ltd., Terumo Corporation, Kawasumi Laboratories Inc., Fuso Pharmaceuticals Industries Ltd., and Toray Industries, Inc. The Company’s operations are subject to extensive governmental regulation by virtually every country in which it operates, including the U.S., at the federal, state and local levels.lessless

                  Key People

                  Dr. Emanuele Gatti

                  CEO, Geographical/Other Corporate Officer/Other Executive Officer

                  Rice Powell

                  CEO/Other Corporate Officer

                  Roberto Fuste

                  CEO, Geographical/Other Corporate Officer

                  Mr. Ronald Kuerbitz

                  CEO, Geographical/Other Corporate Officer

                  Dr. Dieter Schenk

                  Director/Vice Chairman of the Board

                  • Fresenius Medical Care AG & Co. KGaA

                  • Else-Kroener-Strasse 1

                  • Bad Homburg, GM 61352

                  • DEU.Map

                  • Phone: +49 61726090

                  • Fax: -

                  • fmc-ag.com

                  Incorporated

                  1996

                  Employees

                  97,000

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: